nodes	percent_of_prediction	percent_of_DWPC	metapath
Nateglinide—L-Phenylalanine—Liothyronine—hypothyroidism	0.499	1	CrCrCtD
Nateglinide—ALB—Levothyroxine—hypothyroidism	0.0956	0.304	CbGbCtD
Nateglinide—ALB—Liothyronine—hypothyroidism	0.0956	0.304	CbGbCtD
Nateglinide—ALB—Liotrix—hypothyroidism	0.0933	0.297	CbGbCtD
Nateglinide—CYP3A4—Levothyroxine—hypothyroidism	0.03	0.0953	CbGbCtD
Nateglinide—PPARG—brown adipose tissue—hypothyroidism	0.00664	0.0927	CbGeAlD
Nateglinide—Increased appetite—Levothyroxine—hypothyroidism	0.00326	0.0409	CcSEcCtD
Nateglinide—Increased appetite—Dextrothyroxine—hypothyroidism	0.00326	0.0409	CcSEcCtD
Nateglinide—Hypoglycaemia—Levothyroxine—hypothyroidism	0.00314	0.0394	CcSEcCtD
Nateglinide—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.00314	0.0394	CcSEcCtD
Nateglinide—Sweating increased—Levothyroxine—hypothyroidism	0.00258	0.0323	CcSEcCtD
Nateglinide—Sweating increased—Dextrothyroxine—hypothyroidism	0.00258	0.0323	CcSEcCtD
Nateglinide—CYP2C9—urine—hypothyroidism	0.00246	0.0344	CbGeAlD
Nateglinide—Increased appetite—Liotrix—hypothyroidism	0.0024	0.0301	CcSEcCtD
Nateglinide—Hypoglycaemia—Liotrix—hypothyroidism	0.00231	0.029	CcSEcCtD
Nateglinide—Sweating—Levothyroxine—hypothyroidism	0.00227	0.0284	CcSEcCtD
Nateglinide—Sweating—Dextrothyroxine—hypothyroidism	0.00227	0.0284	CcSEcCtD
Nateglinide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—THRA—hypothyroidism	0.0022	0.063	CbGpPWpGaD
Nateglinide—Sweating increased—Liotrix—hypothyroidism	0.0019	0.0238	CcSEcCtD
Nateglinide—CYP3A4—urine—hypothyroidism	0.00188	0.0262	CbGeAlD
Nateglinide—Bronchitis—Liotrix—hypothyroidism	0.00187	0.0235	CcSEcCtD
Nateglinide—CYP2D6—urine—hypothyroidism	0.00185	0.0258	CbGeAlD
Nateglinide—Tremor—Dextrothyroxine—hypothyroidism	0.00173	0.0217	CcSEcCtD
Nateglinide—Tremor—Levothyroxine—hypothyroidism	0.00173	0.0217	CcSEcCtD
Nateglinide—Sweating—Liotrix—hypothyroidism	0.00167	0.0209	CcSEcCtD
Nateglinide—Palpitations—Levothyroxine—hypothyroidism	0.00163	0.0204	CcSEcCtD
Nateglinide—Palpitations—Dextrothyroxine—hypothyroidism	0.00163	0.0204	CcSEcCtD
Nateglinide—PPARG—Nuclear Receptors—THRA—hypothyroidism	0.00163	0.0465	CbGpPWpGaD
Nateglinide—KCNJ11—heart—hypothyroidism	0.00153	0.0214	CbGeAlD
Nateglinide—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00146	0.0183	CcSEcCtD
Nateglinide—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00146	0.0183	CcSEcCtD
Nateglinide—KCNJ11—cardiovascular system—hypothyroidism	0.00145	0.0202	CbGeAlD
Nateglinide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—THRB—hypothyroidism	0.00142	0.0406	CbGpPWpGaD
Nateglinide—ABCC8—heart—hypothyroidism	0.00141	0.0197	CbGeAlD
Nateglinide—ABCC8—FOXA2 and FOXA3 transcription factor networks—NKX2-1—hypothyroidism	0.00136	0.039	CbGpPWpGaD
Nateglinide—ABCC8—cardiovascular system—hypothyroidism	0.00133	0.0186	CbGeAlD
Nateglinide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—NKX2-1—hypothyroidism	0.00132	0.0378	CbGpPWpGaD
Nateglinide—Fatigue—Dextrothyroxine—hypothyroidism	0.0013	0.0163	CcSEcCtD
Nateglinide—Fatigue—Levothyroxine—hypothyroidism	0.0013	0.0163	CcSEcCtD
Nateglinide—PPARG—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00129	0.0368	CbGpPWpGaD
Nateglinide—SLC16A1—heart—hypothyroidism	0.00128	0.0179	CbGeAlD
Nateglinide—UGT1A9—liver—hypothyroidism	0.00128	0.0178	CbGeAlD
Nateglinide—Tremor—Liotrix—hypothyroidism	0.00127	0.0159	CcSEcCtD
Nateglinide—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00123	0.0154	CcSEcCtD
Nateglinide—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00123	0.0154	CcSEcCtD
Nateglinide—SLC16A1—cardiovascular system—hypothyroidism	0.00121	0.0169	CbGeAlD
Nateglinide—Palpitations—Liotrix—hypothyroidism	0.0012	0.015	CcSEcCtD
Nateglinide—Urticaria—Levothyroxine—hypothyroidism	0.0012	0.015	CcSEcCtD
Nateglinide—Urticaria—Dextrothyroxine—hypothyroidism	0.0012	0.015	CcSEcCtD
Nateglinide—Abdominal pain—Levothyroxine—hypothyroidism	0.00119	0.0149	CcSEcCtD
Nateglinide—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00119	0.0149	CcSEcCtD
Nateglinide—ABCC8—pituitary gland—hypothyroidism	0.00118	0.0165	CbGeAlD
Nateglinide—KCNJ11—adrenal gland—hypothyroidism	0.00114	0.016	CbGeAlD
Nateglinide—KCNJ11—thyroid gland—hypothyroidism	0.0011	0.0154	CbGeAlD
Nateglinide—SLC16A1—gonad—hypothyroidism	0.0011	0.0154	CbGeAlD
Nateglinide—Asthenia—Levothyroxine—hypothyroidism	0.00108	0.0135	CcSEcCtD
Nateglinide—Asthenia—Dextrothyroxine—hypothyroidism	0.00108	0.0135	CcSEcCtD
Nateglinide—PPARG—heart—hypothyroidism	0.00108	0.015	CbGeAlD
Nateglinide—SLC16A1—pituitary gland—hypothyroidism	0.00107	0.015	CbGeAlD
Nateglinide—Hyperhidrosis—Liotrix—hypothyroidism	0.00107	0.0134	CcSEcCtD
Nateglinide—KCNJ11—female gonad—hypothyroidism	0.00107	0.0149	CbGeAlD
Nateglinide—Pruritus—Levothyroxine—hypothyroidism	0.00107	0.0134	CcSEcCtD
Nateglinide—Pruritus—Dextrothyroxine—hypothyroidism	0.00107	0.0134	CcSEcCtD
Nateglinide—CYP3A7—liver—hypothyroidism	0.00106	0.0148	CbGeAlD
Nateglinide—ABCC8—adrenal gland—hypothyroidism	0.00105	0.0147	CbGeAlD
Nateglinide—PPARG—Nuclear Receptors—THRB—hypothyroidism	0.00105	0.03	CbGpPWpGaD
Nateglinide—Diarrhoea—Levothyroxine—hypothyroidism	0.00103	0.0129	CcSEcCtD
Nateglinide—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00103	0.0129	CcSEcCtD
Nateglinide—PPARG—cardiovascular system—hypothyroidism	0.00102	0.0142	CbGeAlD
Nateglinide—ABCC8—thyroid gland—hypothyroidism	0.00102	0.0142	CbGeAlD
Nateglinide—ALB—heart—hypothyroidism	0.00101	0.0141	CbGeAlD
Nateglinide—ABCC4—heart—hypothyroidism	0.000979	0.0137	CbGeAlD
Nateglinide—SLC16A1—adrenal gland—hypothyroidism	0.000959	0.0134	CbGeAlD
Nateglinide—Vomiting—Levothyroxine—hypothyroidism	0.000958	0.012	CcSEcCtD
Nateglinide—Vomiting—Dextrothyroxine—hypothyroidism	0.000958	0.012	CcSEcCtD
Nateglinide—Fatigue—Liotrix—hypothyroidism	0.000956	0.012	CcSEcCtD
Nateglinide—Rash—Levothyroxine—hypothyroidism	0.00095	0.0119	CcSEcCtD
Nateglinide—Rash—Dextrothyroxine—hypothyroidism	0.00095	0.0119	CcSEcCtD
Nateglinide—Dermatitis—Dextrothyroxine—hypothyroidism	0.000949	0.0119	CcSEcCtD
Nateglinide—Dermatitis—Levothyroxine—hypothyroidism	0.000949	0.0119	CcSEcCtD
Nateglinide—SLC16A1—thyroid gland—hypothyroidism	0.000925	0.0129	CbGeAlD
Nateglinide—Gastrointestinal pain—Liotrix—hypothyroidism	0.000907	0.0114	CcSEcCtD
Nateglinide—CYP3A7-CYP3A51P—liver—hypothyroidism	0.000904	0.0126	CbGeAlD
Nateglinide—Nausea—Dextrothyroxine—hypothyroidism	0.000895	0.0112	CcSEcCtD
Nateglinide—Nausea—Levothyroxine—hypothyroidism	0.000895	0.0112	CcSEcCtD
Nateglinide—SLC16A1—female gonad—hypothyroidism	0.000894	0.0125	CbGeAlD
Nateglinide—Urticaria—Liotrix—hypothyroidism	0.000881	0.011	CcSEcCtD
Nateglinide—Abdominal pain—Liotrix—hypothyroidism	0.000876	0.011	CcSEcCtD
Nateglinide—KCNJ11—cerebellum—hypothyroidism	0.000874	0.0122	CbGeAlD
Nateglinide—ABCC8—testis—hypothyroidism	0.000871	0.0122	CbGeAlD
Nateglinide—ORM1—blood—hypothyroidism	0.00086	0.012	CbGeAlD
Nateglinide—SLC15A2—heart—hypothyroidism	0.000844	0.0118	CbGeAlD
Nateglinide—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.000836	0.0239	CbGpPWpGaD
Nateglinide—PPARG—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.000829	0.0237	CbGpPWpGaD
Nateglinide—Hypersensitivity—Liotrix—hypothyroidism	0.000817	0.0102	CcSEcCtD
Nateglinide—ABCC8—cerebellum—hypothyroidism	0.000805	0.0112	CbGeAlD
Nateglinide—PPARG—adrenal gland—hypothyroidism	0.000804	0.0112	CbGeAlD
Nateglinide—PPARG—blood—hypothyroidism	0.000804	0.0112	CbGeAlD
Nateglinide—Asthenia—Liotrix—hypothyroidism	0.000795	0.00997	CcSEcCtD
Nateglinide—SLC16A1—testis—hypothyroidism	0.000793	0.0111	CbGeAlD
Nateglinide—SLC15A1—liver—hypothyroidism	0.000788	0.011	CbGeAlD
Nateglinide—Pruritus—Liotrix—hypothyroidism	0.000784	0.00983	CcSEcCtD
Nateglinide—PPARG—thyroid gland—hypothyroidism	0.000776	0.0108	CbGeAlD
Nateglinide—Diarrhoea—Liotrix—hypothyroidism	0.000759	0.0095	CcSEcCtD
Nateglinide—ALB—adrenal gland—hypothyroidism	0.000754	0.0105	CbGeAlD
Nateglinide—PPARG—female gonad—hypothyroidism	0.00075	0.0105	CbGeAlD
Nateglinide—SLC16A1—liver—hypothyroidism	0.000749	0.0105	CbGeAlD
Nateglinide—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—ATP5O—hypothyroidism	0.000735	0.021	CbGpPWpGaD
Nateglinide—Dizziness—Liotrix—hypothyroidism	0.000733	0.00919	CcSEcCtD
Nateglinide—SLC16A1—cerebellum—hypothyroidism	0.000732	0.0102	CbGeAlD
Nateglinide—ABCC4—adrenal gland—hypothyroidism	0.00073	0.0102	CbGeAlD
Nateglinide—ABCC4—blood—hypothyroidism	0.00073	0.0102	CbGeAlD
Nateglinide—SLC15A2—pituitary gland—hypothyroidism	0.000705	0.00984	CbGeAlD
Nateglinide—Vomiting—Liotrix—hypothyroidism	0.000705	0.00883	CcSEcCtD
Nateglinide—ABCC4—thyroid gland—hypothyroidism	0.000705	0.00984	CbGeAlD
Nateglinide—Rash—Liotrix—hypothyroidism	0.000699	0.00876	CcSEcCtD
Nateglinide—Dermatitis—Liotrix—hypothyroidism	0.000698	0.00875	CcSEcCtD
Nateglinide—ABCC4—female gonad—hypothyroidism	0.000681	0.00951	CbGeAlD
Nateglinide—ORM1—liver—hypothyroidism	0.000673	0.00939	CbGeAlD
Nateglinide—PPARG—testis—hypothyroidism	0.000665	0.00929	CbGeAlD
Nateglinide—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A4—hypothyroidism	0.000664	0.019	CbGpPWpGaD
Nateglinide—Nausea—Liotrix—hypothyroidism	0.000658	0.00825	CcSEcCtD
Nateglinide—CYP2C9—heart—hypothyroidism	0.000631	0.00881	CbGeAlD
Nateglinide—SLC15A2—adrenal gland—hypothyroidism	0.00063	0.00879	CbGeAlD
Nateglinide—SLC15A2—blood—hypothyroidism	0.00063	0.00879	CbGeAlD
Nateglinide—PPARG—liver—hypothyroidism	0.000629	0.00878	CbGeAlD
Nateglinide—ALB—testis—hypothyroidism	0.000624	0.00871	CbGeAlD
Nateglinide—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A4—hypothyroidism	0.000616	0.0176	CbGpPWpGaD
Nateglinide—SLC15A2—thyroid gland—hypothyroidism	0.000608	0.00848	CbGeAlD
Nateglinide—ABCC4—testis—hypothyroidism	0.000604	0.00843	CbGeAlD
Nateglinide—CYP2C9—cardiovascular system—hypothyroidism	0.000595	0.00831	CbGeAlD
Nateglinide—ALB—liver—hypothyroidism	0.00059	0.00824	CbGeAlD
Nateglinide—SLC15A2—female gonad—hypothyroidism	0.000587	0.0082	CbGeAlD
Nateglinide—PTGS1—heart—hypothyroidism	0.000576	0.00804	CbGeAlD
Nateglinide—ABCC4—liver—hypothyroidism	0.000571	0.00797	CbGeAlD
Nateglinide—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—hypothyroidism	0.000544	0.0155	CbGpPWpGaD
Nateglinide—PTGS1—cardiovascular system—hypothyroidism	0.000544	0.00759	CbGeAlD
Nateglinide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.000543	0.0155	CbGpPWpGaD
Nateglinide—SLC15A2—testis—hypothyroidism	0.000521	0.00727	CbGeAlD
Nateglinide—ALB—Transport of organic anions—AVP—hypothyroidism	0.000506	0.0145	CbGpPWpGaD
Nateglinide—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—hypothyroidism	0.000505	0.0144	CbGpPWpGaD
Nateglinide—PTGS1—pituitary gland—hypothyroidism	0.000481	0.00672	CbGeAlD
Nateglinide—SLC15A2—cerebellum—hypothyroidism	0.000481	0.00671	CbGeAlD
Nateglinide—CYP3A5—blood—hypothyroidism	0.000478	0.00668	CbGeAlD
Nateglinide—CYP2C9—blood—hypothyroidism	0.000471	0.00657	CbGeAlD
Nateglinide—ABCC4—NRF2 pathway—SLC5A7—hypothyroidism	0.000449	0.0128	CbGpPWpGaD
Nateglinide—CYP3A5—female gonad—hypothyroidism	0.000446	0.00623	CbGeAlD
Nateglinide—ALB—FOXA2 and FOXA3 transcription factor networks—NKX2-1—hypothyroidism	0.00044	0.0126	CbGpPWpGaD
Nateglinide—PTGS1—adrenal gland—hypothyroidism	0.00043	0.006	CbGeAlD
Nateglinide—PTGS1—blood—hypothyroidism	0.00043	0.006	CbGeAlD
Nateglinide—PTGS1—thyroid gland—hypothyroidism	0.000415	0.00579	CbGeAlD
Nateglinide—PPARG—Regulation of retinoblastoma protein—BGLAP—hypothyroidism	0.000409	0.0117	CbGpPWpGaD
Nateglinide—PTGS1—female gonad—hypothyroidism	0.000401	0.0056	CbGeAlD
Nateglinide—PTGS1—Prostaglandin Synthesis and Regulation—PRL—hypothyroidism	0.000396	0.0113	CbGpPWpGaD
Nateglinide—UGT1A9—NRF2 pathway—SLC5A7—hypothyroidism	0.000388	0.0111	CbGpPWpGaD
Nateglinide—SLC16A1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00038	0.0109	CbGpPWpGaD
Nateglinide—ABCC8—Neuronal System—SLC5A7—hypothyroidism	0.000376	0.0107	CbGpPWpGaD
Nateglinide—CYP3A5—liver—hypothyroidism	0.000374	0.00522	CbGeAlD
Nateglinide—CYP2C9—liver—hypothyroidism	0.000368	0.00514	CbGeAlD
Nateglinide—KCNJ11—Neuronal System—SLC5A7—hypothyroidism	0.000364	0.0104	CbGpPWpGaD
Nateglinide—CYP3A4—blood—hypothyroidism	0.000359	0.00501	CbGeAlD
Nateglinide—SLC15A2—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000358	0.0102	CbGpPWpGaD
Nateglinide—PTGS1—testis—hypothyroidism	0.000356	0.00496	CbGeAlD
Nateglinide—CYP2D6—blood—hypothyroidism	0.000353	0.00493	CbGeAlD
Nateglinide—PPARG—Generic Transcription Pathway—ZNF764—hypothyroidism	0.000345	0.00985	CbGpPWpGaD
Nateglinide—SLC15A1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000332	0.00949	CbGpPWpGaD
Nateglinide—CYP2D6—female gonad—hypothyroidism	0.00033	0.0046	CbGeAlD
Nateglinide—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—hypothyroidism	0.00032	0.00915	CbGpPWpGaD
Nateglinide—SLC16A1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000315	0.009	CbGpPWpGaD
Nateglinide—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—hypothyroidism	0.000297	0.00849	CbGpPWpGaD
Nateglinide—SLC15A2—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000297	0.00847	CbGpPWpGaD
Nateglinide—CYP2D6—testis—hypothyroidism	0.000292	0.00408	CbGeAlD
Nateglinide—PPARG—Circadian rythm related genes—NKX2-1—hypothyroidism	0.00029	0.00829	CbGpPWpGaD
Nateglinide—CYP3A4—liver—hypothyroidism	0.000281	0.00392	CbGeAlD
Nateglinide—CYP2D6—liver—hypothyroidism	0.000276	0.00386	CbGeAlD
Nateglinide—SLC15A1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000275	0.00787	CbGpPWpGaD
Nateglinide—CYP2D6—cerebellum—hypothyroidism	0.00027	0.00377	CbGeAlD
Nateglinide—SLC22A6—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000247	0.00705	CbGpPWpGaD
Nateglinide—ABCC8—Neuronal System—NEFL—hypothyroidism	0.000242	0.00692	CbGpPWpGaD
Nateglinide—KCNJ11—Neuronal System—NEFL—hypothyroidism	0.000235	0.00671	CbGpPWpGaD
Nateglinide—PPARG—Generic Transcription Pathway—THRA—hypothyroidism	0.000222	0.00635	CbGpPWpGaD
Nateglinide—SLC22A6—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000204	0.00584	CbGpPWpGaD
Nateglinide—ABCC8—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000202	0.00577	CbGpPWpGaD
Nateglinide—SLC16A1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000193	0.00552	CbGpPWpGaD
Nateglinide—ALB—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	0.000188	0.00537	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000182	0.0052	CbGpPWpGaD
Nateglinide—ABCC4—NRF2 pathway—SLC5A5—hypothyroidism	0.00018	0.00513	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000169	0.00482	CbGpPWpGaD
Nateglinide—ABCC8—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000167	0.00478	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—ZNF764—hypothyroidism	0.000166	0.00474	CbGpPWpGaD
Nateglinide—SLC16A1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00016	0.00457	CbGpPWpGaD
Nateglinide—PPARG—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.000158	0.00452	CbGpPWpGaD
Nateglinide—UGT1A9—NRF2 pathway—SLC5A5—hypothyroidism	0.000155	0.00444	CbGpPWpGaD
Nateglinide—SLC16A1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000152	0.00434	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000151	0.00431	CbGpPWpGaD
Nateglinide—ABCC4—Platelet degranulation—IGF1—hypothyroidism	0.000146	0.00418	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000144	0.00411	CbGpPWpGaD
Nateglinide—PPARG—Generic Transcription Pathway—THRB—hypothyroidism	0.000143	0.00409	CbGpPWpGaD
Nateglinide—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000143	0.00409	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00014	0.004	CbGpPWpGaD
Nateglinide—ABCC4—Response to elevated platelet cytosolic Ca2+—IGF1—hypothyroidism	0.000139	0.00398	CbGpPWpGaD
Nateglinide—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000139	0.00398	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—IYD—hypothyroidism	0.000136	0.0039	CbGpPWpGaD
Nateglinide—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000133	0.00379	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—IYD—hypothyroidism	0.000132	0.00378	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—IYD—hypothyroidism	0.00013	0.00373	CbGpPWpGaD
Nateglinide—ALB—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000128	0.00366	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000125	0.00358	CbGpPWpGaD
Nateglinide—SLC16A1—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.00012	0.00342	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000119	0.00341	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—CLTC—hypothyroidism	0.000118	0.00338	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—ATP5O—hypothyroidism	0.000116	0.00332	CbGpPWpGaD
Nateglinide—CYP3A7—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000113	0.00322	CbGpPWpGaD
Nateglinide—SLC15A2—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000113	0.00322	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—ATP5O—hypothyroidism	0.000113	0.00322	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—ATP5O—hypothyroidism	0.000111	0.00317	CbGpPWpGaD
Nateglinide—PPARG—Circadian rythm related genes—AVP—hypothyroidism	0.00011	0.00315	CbGpPWpGaD
Nateglinide—PTGS1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000109	0.00312	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—TPO—hypothyroidism	0.000109	0.00312	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—THRA—hypothyroidism	0.000107	0.00306	CbGpPWpGaD
Nateglinide—ALB—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000106	0.00303	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—SH2B3—hypothyroidism	0.000106	0.00303	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—TPO—hypothyroidism	0.000106	0.00302	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	0.000105	0.00301	CbGpPWpGaD
Nateglinide—SLC15A1—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000105	0.00299	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—TPO—hypothyroidism	0.000104	0.00298	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000104	0.00297	CbGpPWpGaD
Nateglinide—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000101	0.00287	CbGpPWpGaD
Nateglinide—PPARG—Adipogenesis—IGF1—hypothyroidism	9.98e-05	0.00285	CbGpPWpGaD
Nateglinide—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	9.86e-05	0.00282	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—IYD—hypothyroidism	9.78e-05	0.0028	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—IYD—hypothyroidism	8.41e-05	0.0024	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—ATP5O—hypothyroidism	8.32e-05	0.00238	CbGpPWpGaD
Nateglinide—CYP3A5—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	8.15e-05	0.00233	CbGpPWpGaD
Nateglinide—ABCC8—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	8.07e-05	0.00231	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—SH2B3—hypothyroidism	7.91e-05	0.00226	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—TPO—hypothyroidism	7.82e-05	0.00223	CbGpPWpGaD
Nateglinide—SLC22A6—SLC-mediated transmembrane transport—AVP—hypothyroidism	7.76e-05	0.00222	CbGpPWpGaD
Nateglinide—SLC16A1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	7.72e-05	0.00221	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—NKX2-5—hypothyroidism	7.62e-05	0.00218	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—VAV3—hypothyroidism	7.28e-05	0.00208	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	7.27e-05	0.00208	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	7.25e-05	0.00207	CbGpPWpGaD
Nateglinide—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	7.15e-05	0.00204	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—ATP5O—hypothyroidism	7.15e-05	0.00204	CbGpPWpGaD
Nateglinide—UGT1A9—Biological oxidations—POMC—hypothyroidism	7.12e-05	0.00204	CbGpPWpGaD
Nateglinide—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	7.09e-05	0.00203	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—IYD—hypothyroidism	7.07e-05	0.00202	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—THRB—hypothyroidism	6.89e-05	0.00197	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—IYD—hypothyroidism	6.85e-05	0.00196	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	6.75e-05	0.00193	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—TPO—hypothyroidism	6.72e-05	0.00192	CbGpPWpGaD
Nateglinide—ALB—Platelet degranulation—IGF1—hypothyroidism	6.62e-05	0.00189	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	6.51e-05	0.00186	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	6.49e-05	0.00185	CbGpPWpGaD
Nateglinide—ABCC8—Transmembrane transport of small molecules—AVP—hypothyroidism	6.36e-05	0.00182	CbGpPWpGaD
Nateglinide—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—hypothyroidism	6.31e-05	0.0018	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	6.23e-05	0.00178	CbGpPWpGaD
Nateglinide—SLC16A1—Transmembrane transport of small molecules—AVP—hypothyroidism	6.08e-05	0.00174	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—ATP5O—hypothyroidism	6.01e-05	0.00172	CbGpPWpGaD
Nateglinide—CYP3A7—Biological oxidations—POMC—hypothyroidism	5.99e-05	0.00171	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—ATP5O—hypothyroidism	5.83e-05	0.00166	CbGpPWpGaD
Nateglinide—PTGS1—Biological oxidations—POMC—hypothyroidism	5.81e-05	0.00166	CbGpPWpGaD
Nateglinide—CYP2D6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	5.8e-05	0.00166	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	5.75e-05	0.00164	CbGpPWpGaD
Nateglinide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	5.75e-05	0.00164	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—AVP—hypothyroidism	5.72e-05	0.00164	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—TPO—hypothyroidism	5.65e-05	0.00161	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—VAV3—hypothyroidism	5.57e-05	0.00159	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—TPO—hypothyroidism	5.48e-05	0.00157	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—VAV3—hypothyroidism	5.43e-05	0.00155	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	5.4e-05	0.00154	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—AVP—hypothyroidism	5.31e-05	0.00152	CbGpPWpGaD
Nateglinide—ALB—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	5.12e-05	0.00146	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—IYD—hypothyroidism	5.11e-05	0.00146	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	5.08e-05	0.00145	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—TSHB—hypothyroidism	5.05e-05	0.00144	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	5.01e-05	0.00143	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—TSHB—hypothyroidism	4.9e-05	0.0014	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—TSHB—hypothyroidism	4.83e-05	0.00138	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	4.77e-05	0.00136	CbGpPWpGaD
Nateglinide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	4.68e-05	0.00134	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—AVP—hypothyroidism	4.53e-05	0.00129	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PIK3C2A—hypothyroidism	4.5e-05	0.00129	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—IGF1—hypothyroidism	4.49e-05	0.00128	CbGpPWpGaD
Nateglinide—ALB—Metabolism—IYD—hypothyroidism	4.4e-05	0.00126	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PIK3C2A—hypothyroidism	4.37e-05	0.00125	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—ATP5O—hypothyroidism	4.35e-05	0.00124	CbGpPWpGaD
Nateglinide—CYP3A5—Biological oxidations—POMC—hypothyroidism	4.33e-05	0.00124	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PIK3C2A—hypothyroidism	4.3e-05	0.00123	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—TPO—hypothyroidism	4.09e-05	0.00117	CbGpPWpGaD
Nateglinide—ALB—SLC-mediated transmembrane transport—AVP—hypothyroidism	4.03e-05	0.00115	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—AVP—hypothyroidism	3.94e-05	0.00113	CbGpPWpGaD
Nateglinide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	3.79e-05	0.00108	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—SLC5A5—hypothyroidism	3.78e-05	0.00108	CbGpPWpGaD
Nateglinide—ALB—Metabolism—ATP5O—hypothyroidism	3.74e-05	0.00107	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—SLC5A5—hypothyroidism	3.67e-05	0.00105	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—IYD—hypothyroidism	3.63e-05	0.00104	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—TSHB—hypothyroidism	3.62e-05	0.00103	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—SLC5A5—hypothyroidism	3.61e-05	0.00103	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—IYD—hypothyroidism	3.6e-05	0.00103	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—SH2B3—hypothyroidism	3.58e-05	0.00102	CbGpPWpGaD
Nateglinide—ALB—Metabolism—TPO—hypothyroidism	3.52e-05	0.00101	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—IGF1—hypothyroidism	3.34e-05	0.000956	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	3.26e-05	0.000932	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PIK3C2A—hypothyroidism	3.23e-05	0.000922	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.18e-05	0.00091	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—TSHB—hypothyroidism	3.11e-05	0.000889	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ATP5O—hypothyroidism	3.09e-05	0.000883	CbGpPWpGaD
Nateglinide—CYP2D6—Biological oxidations—POMC—hypothyroidism	3.08e-05	0.00088	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ATP5O—hypothyroidism	3.06e-05	0.000875	CbGpPWpGaD
Nateglinide—CYP2C9—Biological oxidations—POMC—hypothyroidism	3.05e-05	0.000873	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	2.94e-05	0.000839	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—TPO—hypothyroidism	2.9e-05	0.00083	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—TPO—hypothyroidism	2.88e-05	0.000823	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PIK3C2A—hypothyroidism	2.77e-05	0.000792	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.74e-05	0.000782	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—SLC5A5—hypothyroidism	2.71e-05	0.000774	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	2.67e-05	0.000762	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—TSHB—hypothyroidism	2.62e-05	0.000748	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.6e-05	0.000744	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—TSHB—hypothyroidism	2.54e-05	0.000725	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—VAV3—hypothyroidism	2.46e-05	0.000702	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—IYD—hypothyroidism	2.38e-05	0.000679	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PIK3C2A—hypothyroidism	2.33e-05	0.000666	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—SLC5A5—hypothyroidism	2.33e-05	0.000666	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PIK3C2A—hypothyroidism	2.26e-05	0.000646	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.23e-05	0.000637	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—AVP—hypothyroidism	2.05e-05	0.000586	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ATP5O—hypothyroidism	2.02e-05	0.000577	CbGpPWpGaD
Nateglinide—CYP3A4—Biological oxidations—POMC—hypothyroidism	2.01e-05	0.000575	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—POMC—hypothyroidism	1.98e-05	0.000565	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—SLC5A5—hypothyroidism	1.96e-05	0.00056	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—POMC—hypothyroidism	1.92e-05	0.000548	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—TPO—hypothyroidism	1.9e-05	0.000543	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—SLC5A5—hypothyroidism	1.9e-05	0.000543	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—TSHB—hypothyroidism	1.89e-05	0.00054	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—POMC—hypothyroidism	1.89e-05	0.00054	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PIK3C2A—hypothyroidism	1.69e-05	0.000482	CbGpPWpGaD
Nateglinide—ALB—Metabolism—TSHB—hypothyroidism	1.63e-05	0.000465	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—IGF1—hypothyroidism	1.51e-05	0.000432	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PIK3C2A—hypothyroidism	1.45e-05	0.000415	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.43e-05	0.000409	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—POMC—hypothyroidism	1.42e-05	0.000405	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—SLC5A5—hypothyroidism	1.42e-05	0.000405	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—TSHB—hypothyroidism	1.34e-05	0.000384	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—TSHB—hypothyroidism	1.33e-05	0.000381	CbGpPWpGaD
Nateglinide—ALB—Metabolism—SLC5A5—hypothyroidism	1.22e-05	0.000348	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—POMC—hypothyroidism	1.22e-05	0.000348	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	1.2e-05	0.000343	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PIK3C2A—hypothyroidism	1.19e-05	0.00034	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.17e-05	0.000335	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—POMC—hypothyroidism	1.02e-05	0.000293	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—SLC5A5—hypothyroidism	1.01e-05	0.000288	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—SLC5A5—hypothyroidism	9.98e-06	0.000285	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—POMC—hypothyroidism	9.93e-06	0.000284	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—TSHB—hypothyroidism	8.79e-06	0.000251	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	7.84e-06	0.000224	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—POMC—hypothyroidism	7.41e-06	0.000212	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SLC5A5—hypothyroidism	6.58e-06	0.000188	CbGpPWpGaD
Nateglinide—ALB—Metabolism—POMC—hypothyroidism	6.38e-06	0.000182	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—POMC—hypothyroidism	5.27e-06	0.000151	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—POMC—hypothyroidism	5.22e-06	0.000149	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—POMC—hypothyroidism	3.44e-06	9.84e-05	CbGpPWpGaD
